{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:31:17Z","timestamp":1790483477618,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","award":["ED003"],"award-info":[{"award-number":["ED003"]}],"id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA219603"],"award-info":[{"award-number":["CA219603"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE028172"],"award-info":[{"award-number":["DE028172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jid.2020.08.023","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T21:27:47Z","timestamp":1601328467000},"page":"903-912.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-3035","authenticated-orcid":false,"given":"Lina","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9302-3786","authenticated-orcid":false,"given":"Anne Catherine","family":"Bretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-7685","authenticated-orcid":false,"given":"Jan","family":"Gravemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4663-7966","authenticated-orcid":false,"given":"Ivelina","family":"Spassova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-1630","authenticated-orcid":false,"given":"Shakhlo","family":"Muminova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7862-3695","authenticated-orcid":false,"given":"Thilo","family":"Gambichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8875-5501","authenticated-orcid":false,"given":"Ashwin","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2900-8834","authenticated-orcid":false,"given":"Soldano","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-653X","authenticated-orcid":false,"given":"J\u00fcrgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2020.08.023_bib1","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2020.08.023_bib2","unstructured":"Bartz R, Behling T, Reimann P, Hermann F. Preclinical rationale and clinical design for the combination of domatinostat with avelumab in Merkel cell carcinoma patients: the MERKLIN and MERKLIN 2 studies. Paper presented at: 1st International Symposium on Merkel Cell Carcinoma. 21\u201322 October 2019; Tampa, FL."},{"key":"10.1016\/j.jid.2020.08.023_bib3","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2020.08.023_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jid.2020.08.023_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s40425-019-0745-3","article-title":"Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)","volume":"7","author":"Bretz","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jid.2020.08.023_bib6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00262-018-2131-2","article-title":"Defective HLA class I antigen processing machinery in cancer","volume":"67","author":"Cai","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2020.08.023_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jid.2020.08.023_bib8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.neo.2018.10.003","article-title":"Neuroendocrine key regulator gene expression in Merkel cell carcinoma","volume":"20","author":"Chteinberg","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.jid.2020.08.023_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biocel.2018.03.004","article-title":"HDAC inhibitors as epigenetic regulators for cancer immunotherapy","volume":"98","author":"Conte","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jid.2020.08.023_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.18632\/oncotarget.23070","article-title":"HDAC inhibitor PAC-320 induces G2\/M cell cycle arrest and apoptosis in human prostate cancer","volume":"9","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2020.08.023_bib11","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1158\/1078-0432.CCR-18-1184","article-title":"Circulating cell-free miR-375 as surrogate marker of tumor burden in Merkel cell carcinoma","volume":"24","author":"Fan","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.08.023_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbrc.2003.09.043","article-title":"Role of class I and class II histone deacetylases in carcinoma cells using siRNA","volume":"310","author":"Glaser","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2020.08.023_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jid.2020.08.023_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13072-015-0021-9","article-title":"Cells adapt to the epigenomic disruption caused by histone deacetylase inhibitors through a coordinated, chromatin-mediated transcriptional response","volume":"8","author":"Halsall","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.jid.2020.08.023_bib15","doi-asserted-by":"crossref","unstructured":"Hamm S, Wulff T, Kronthaler K, Schrepfer S, Parnitzke U, Bretz AC, et\u00a0al. 4SC-202 increases immunogenicity of tumor cells, induces infiltration of tumor microenvironment with cytotoxic T cells, and primes tumors for combinations with different cancer immunotherapy approaches. Paper presented at: AACR Annual Meeting 2018. 14\u201318 April 2018; Chicago, IL.","DOI":"10.1016\/j.ejca.2018.01.040"},{"key":"10.1016\/j.jid.2020.08.023_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2020.08.023_bib17","doi-asserted-by":"crossref","first-page":"e2879","DOI":"10.1038\/cddis.2017.239","article-title":"Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells","volume":"8","author":"Haydn","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2020.08.023_bib18","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1128\/JVI.02400-09","article-title":"Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens","volume":"84","author":"Houben","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jid.2020.08.023_bib19","doi-asserted-by":"crossref","first-page":"8797206","DOI":"10.1155\/2016\/8797206","article-title":"HDAC inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases","volume":"2016","author":"Hull","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jid.2020.08.023_bib20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pro.3142","article-title":"Stepwise assembly of functional C-terminal REST\/NRSF transcriptional repressor complexes as a drug target","volume":"26","author":"Inui","year":"2017","journal-title":"Protein Sci"},{"key":"10.1016\/j.jid.2020.08.023_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2404464","article-title":"Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?","volume":"21","author":"Karagiannis","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2020.08.023_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40425-017-0310-x","article-title":"Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after \u2265 1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial","volume":"6","author":"Kaufman","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.jid.2020.08.023_bib23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1158\/1535-7163.MCT-10-0779","article-title":"Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor","volume":"10","author":"Kong","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2020.08.023_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.17219\/acem\/26940","article-title":"Prognostic implications of discordant results of myocardial perfusion single-photon emission computed tomography and exercise ECG test in patients with stable angina","volume":"24","author":"Kowalczyk","year":"2015","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jid.2020.08.023_bib25","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1038\/cddis.2010.21","article-title":"Histone deacetylase 1 and 2 differentially regulate apoptosis by opposing effects on extracellular signal-regulated kinase 1\/2","volume":"1","author":"Lei","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2020.08.023_bib26","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3892\/ijo.2016.3478","article-title":"Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: a proteomic approach","volume":"48","author":"Li","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jid.2020.08.023_bib27","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jid.2020.08.023_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/brainsci7110147","article-title":"4SC-202 as a potential treatment for the pediatric brain tumor medulloblastoma","volume":"7","author":"Messerli","year":"2017","journal-title":"Brain Sci"},{"key":"10.1016\/j.jid.2020.08.023_bib29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/14653249.2010.529893","article-title":"Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103","volume":"13","author":"Moreno-Bost","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jid.2020.08.023_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.18.01896","article-title":"Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy","volume":"37","author":"Nghiem","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2020.08.023_bib31","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1158\/2326-6066.CIR-14-0005","article-title":"Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma","volume":"2","author":"Paulson","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jid.2020.08.023_bib32","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/s41467-018-06300-3","article-title":"Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA","volume":"9","author":"Paulson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.08.023_bib33","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/sj.onc.1208594","article-title":"Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications","volume":"24","author":"Raffaghello","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2020.08.023_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jim.2017.07.016","article-title":"Monitoring native HLA-I trimer specific antibodies in Luminex multiplex single antigen bead assay: evaluation of beadsets from different manufacturers","volume":"450","author":"Ravindranath","year":"2017","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jid.2020.08.023_bib35","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/s41598-017-02608-0","article-title":"Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma","volume":"7","author":"Ritter","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2020.08.023_bib36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.08.023_bib37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/ijc.32280","article-title":"Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: integration pattern suggest that large T antigen truncating events occur before or during integration","volume":"145","author":"Schrama","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2020.08.023_bib38","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1158\/0008-5472.CAN-07-5270","article-title":"Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors","volume":"68","author":"Setiadi","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.08.023_bib39","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1158\/0008-5472.CAN-05-0599","article-title":"Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B","volume":"65","author":"Skov","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2020.08.023_bib40","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1158\/1078-0432.CCR-19-2244","article-title":"Predominance of central memory T cells with high T-cell receptor repertoire diversity is associated with response to PD-1\/PD-L1 inhibition in Merkel cell carcinoma","volume":"26","author":"Spassova","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.08.023_bib41","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2020.08.023_bib42","first-page":"3512","article-title":"Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis","volume":"8","author":"Tyagi","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.08.023_bib43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00262-019-02341-9","article-title":"MHC class-I downregulation in PD-1\/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series","volume":"68","author":"Ugurel","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jid.2020.08.023_bib44","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.jid.2020.08.023_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ejh.13188","article-title":"Phase I study of domatinostat (4SC-202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies","volume":"102","author":"von Tresckow","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jid.2020.08.023_bib46","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1038\/cddis.2016.138","article-title":"Erianin induces G2\/M-phase arrest, apoptosis, and autophagy via the ROS\/JNK signaling pathway in human osteosarcoma cells in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Wang","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2020.08.023_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jim.2005.02.006","article-title":"A\u00a0method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections","volume":"299","author":"Wang","year":"2005","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jid.2020.08.023_bib48","doi-asserted-by":"crossref","first-page":"e27414","DOI":"10.4161\/onci.27414","article-title":"The anticancer effects of HDAC inhibitors require the immune system","volume":"3","author":"West","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jid.2020.08.023_bib49","doi-asserted-by":"crossref","first-page":"7343965","DOI":"10.1155\/2016\/7343965","article-title":"Is hydrogen peroxide a suitable apoptosis inducer for all cell types?","volume":"2016","author":"Xiang","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jid.2020.08.023_bib50","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2020.08.023_bib51","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-15-2584","article-title":"HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma","volume":"22","author":"Zheng","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2020.08.023_bib52","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J\u00a0Cell Mol Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20320741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X20320741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:45:08Z","timestamp":1762206308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X20320741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0022202X20320741"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2020.08.023","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2020.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}